4-Hydroxytestosterone
![]() | |
![]() | |
| Names | |
|---|---|
| IUPAC name
4,17-Dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one | |
| Other names
4,17β-Dihydroxy-4-androstene-3-one; (17β)-4,17-dihydroxyandrost-4-en-3-one | |
| Identifiers | |
| 2141-17-5 | |
| ChemSpider | 141138 |
| DrugBank | DB01485 |
| Jmol interactive 3D | Image |
| PubChem | 160615 |
| UNII | 912GOZ167T |
| |
| |
| Properties | |
| C19H28O3 | |
| Molar mass | 304.42 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
4-Hydroxytestosterone (4-OHT), also known as 4,17β-dihydroxy-4-androstene-3-one, is an anabolic steroid. It was first patented by G.D. Searle & Company in 1955 and is testosterone with a hydroxy group at the four position. 4-OHT has moderate anabolic, mild androgenic, and anti-aromatase properties and is similar to the steroid clostebol.
See also
References
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Thursday, December 31, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

